Literature DB >> 24210913

Re: Christoph A. Von Klot, Markus A. Kuczyk, Axel S. Merseburger. No androgen withdrawal syndrome for enzalutamide: a report of disease dynamics in the postchemotherapy setting. Eur Urol 2014;65:258-9: Enzalutamide withdrawal syndrome: fact or fiction?

Andres J Schrader1, Mark G Schrader1, Marcus V Cronauer2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24210913     DOI： 10.1016/j.eururo.2013.10.034

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  2 in total

1.  Is there an anti-androgen withdrawal syndrome for enzalutamide?

Authors:  Christoph A J von Klot; Mario W Kramer; Alena Böker; Thomas R W Herrmann; Inga Peters; Markus A Kuczyk; Uwe Ligges; Jürgen E Gschwend; Margitta Retz; Sebastian C Schmid; Arnulf Stenzl; Christian Schwentner; Tilmann Todenhöfer; Michael Stöckle; Carsten-Henning Ohlmann; Ines Azone; René Mager; Georg Bartsch; Axel Haferkamp; Axel Heidenreich; Charlotte Piper; Axel S Merseburger
Journal:  World J Urol       Date:  2014-04-02       Impact factor: 4.226

Review 2.  Profile of apalutamide in the treatment of metastatic castration-resistant prostate cancer: evidence to date.

Authors:  Julio T Chong; William K Oh; Bobby C Liaw
Journal:  Onco Targets Ther       Date:  2018-04-12       Impact factor: 4.147
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.